Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired Pneumonia
Xanthe Brands(University of Amsterdam), Tom van der Poll(Amsterdam Neuroscience), Tjitske S. R. van Engelen(University of Amsterdam), Alex R. Schuurman(Amsterdam Neuroscience), Fabrice Uhel(Hôpital Louis-Mourier), René Lutter(Amsterdam Neuroscience), Marc J. M. Bonten(Utrecht University), Hessel Peters‐Sengers(Amsterdam Neuroscience), Bastiaan W. Haak(Amsterdam UMC Location University of Amsterdam), Brendon P. Scicluna(Academic Medical Center), F.M.C. de Vries(Amsterdam University Medical Centers), Olaf L. Cremer(University Medical Center Utrecht), Marcus J. Schultz(University of St.Gallen)
Cited by 18
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k